I think thats what's been going on over the last quarter not that I actually know.  Eversana is nowhere.  

A deal, if it happens, typically takes 3 no more than 6 month to process.  They have to move thru due diligence swiftly.  

And when the due diligence process is underway, things go totally dark which is totally the case here and which is why these deals must happen sooner than later.  

It's been 3 months now and counting since we have heard anything from RVX.  Total crickets.  

So my best guess having been involved with about 6 acquisition deals myself on both sides of the equation, is that we will hear something no later than by the end of Q1 on this front.  

Again I don't know anything but the past 3 months feels exactly as that.  Negotiations may be underway.  

So whether it's a buyout or new funding and or a change in leadership I've no clue.  But there definitely something rotten in the state of Denmark. 

Happy New Year to all and may 2023 indeed be a Prime year!

10BagR